# Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients

> **NCT03250572** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 113 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DIAGNOSTIC_TEST:** serum ferritin

## Key facts

- **NCT ID:** NCT03250572
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-07
- **Final completion:** 2016-11
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03250572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03250572, "Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03250572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*